John A Lambert Net Worth & Insider Trades
John A Lambert - Director, Novavax Inc
What is John A Lambert's Net Worth?
The current estimated net worth of Novavax Inc's Director, John A Lambert, is estimated to be about $1.23M . John A Lambert owns about 114,746 units of Novavax Inc common stock. In the last 3 years at Novavax Inc, John A Lambert has sold an estimated value of $0 worth.
What is John A Lambert's Past Insider Trading?
In total, John A Lambert has made about 3 transactions over 3 years of their time at Novavax Inc. John A Lambert usually trades in August, March and April, with the busiest year in 2008, 2007 and 2010. The most recent transaction was a purchase order of 14,746 units , worth over $0 on August 4, 2008.
John A Lambert
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was John A Lambert's Salary in 2020?
As Director of Novavax Inc, John A Lambert has a total base salary of $402,842 . The vast majority of their compensation came in the form of other earnings, plans or compensations of $20,606,814 , option awards of $18,924,907 , other earnings, plans or compensations of $20,606,814 , and other compensation of $11,400 .
Novavax Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|---|---|
| Stanley C. Erck Stanley C. Erck | 2020 | $657,181 | $48,086,018 | $44,115,244 | $48,086,018 | $11,400 | $48,086,018 |
| Stanley C. Erck Stanley C. Erck | 2019 | $642,720 | $2,438,562 | $986,660 | $2,438,562 | $11,200 | $2,438,562 |
| Stanley C. Erck Stanley C. Erck | 2018 | $638,040 | $4,158,398 | $3,509,358 | $4,158,398 | $11,000 | $4,158,398 |
| Gregory F. Covino | 2020 | $55,000 | $1,417,774 | $659,967 | $1,417,774 | $8,032 | $1,417,774 |
| Gregory F. Covino | 2019 | $― | $― | $― | $― | $― | $― |
| Gregory F. Covino | 2018 | $― | $― | $― | $― | $― | $― |
| Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2020 | $483,443 | $24,923,376 | $22,859,741 | $24,923,376 | $11,400 | $24,923,376 |
| Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2019 | $470,453 | $1,875,198 | $819,421 | $1,875,198 | $11,200 | $1,875,198 |
| Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2018 | $460,125 | $1,681,456 | $1,131,189 | $1,681,456 | $11,000 | $1,681,456 |
| John J. Trizzino John J. Trizzino | 2020 | $415,892 | $21,327,954 | $19,819,717 | $21,327,954 | $11,400 | $21,327,954 |
| John J. Trizzino John J. Trizzino | 2019 | $390,701 | $1,465,602 | $584,103 | $1,465,602 | $9,546 | $1,465,602 |
| John J. Trizzino John J. Trizzino | 2018 | $378,078 | $1,329,776 | $890,700 | $1,329,776 | $7,500 | $1,329,776 |
| John A. Herrmann III John A. Herrmann III | 2020 | $402,842 | $20,606,814 | $18,924,907 | $20,606,814 | $11,400 | $20,606,814 |
| John A. Herrmann III John A. Herrmann III | 2019 | $378,591 | $1,353,416 | $488,397 | $1,353,416 | $11,200 | $1,353,416 |
| John A. Herrmann III John A. Herrmann III | 2018 | $362,695 | $1,137,576 | $712,560 | $1,137,576 | $11,000 | $1,137,576 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1000694/000110465921060332/tm212692d3_def14a.htm
What are Novavax Inc's Past Insider Trades?
Novavax Inc's most recent insider trade came on April 4, 2022 by James Young who sold 12,500 units worth $919.76K . In the last 19 years, insiders at Novavax Inc have sold an estimated value of $286.98M and bought an estimated value of $38.15M worth of shares. Insider trading is most common in March, with the busiest year in 2021. The most active traders at the company are Gregory Glenn, President, Gary Evans, Director, and John A. Herrmann III, EVP .
NOVAVAX INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||